This trial is completed!
Search for a recruiting clinical trial for your condition
Your journey
1What's a trial
4Get in touch
More info
You can access this
clinical trial
if you have
Esophageal Cancer
and you are
over 18
years old
The primary goal of this phase is to monitor the long-term effects.
The treatment is already on the market.
Show me locations

The purpose

The scope of the trial is to predict the early complete clinical response to exclusive concomitant radiochemotherapy in esophageal cancer by the study of the pre- and per- therapeutic proteomic profile.

Provided treatments

  • Procedure: Blood sampling
  • Radiation: Radiation
  • Drug: Chemotherapy (Fluorouracil and Cisplatin)
Tris trial is registered with FDA with number: NCT00911092. The sponsor of the trial is Centre Oscar Lambret and it is looking for 50 volunteers for the current phase.
Official trial title:
Study of Predictive Proteomic Factors of the Response to Exclusive Concomitant Radiochemotherapy in Oesophageal Cancer